JAK inhibition induces silencing of T Helper cytokine secretion and a profound reduction in T regulatory cells-Reference-Cited by-同舟云学术

JAK inhibition induces silencing of T Helper cytokine secretion and a profound reduction in T regulatory cells

Published:2015-06-15 Issue:1 Volume:171 Page:60-73
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Keohane Clodagh¹²,Kordasti Shahram²³,Seidl Thomas²,Perez Abellan Pilar²,Thomas Nicholas S. B.²,Harrison Claire N.¹,McLornan Donal P.¹³,Mufti Ghulam J.²³

Affiliation:

1. Department of Haematology; Guy's and St Thomas’ NHS Foundation Trust; London UK

2. Department of Haematological Medicine; Kings College London; London UK

3. Department of Haematological Medicine; Kings College Hospital NHS Foundation Trust; London UK

Funder

Gabrielle's Angel Foundation for Cancer Research

Novartis UK

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13519/fullpdf

Reference49 articles.

1. IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients;Ahmadzadeh;Blood,2006

2. The multifaceted role of Th17 lymphocytes and their associated cytokines in cancer;Alizadeh;Clinical and Developmental Immunology,2013

3. CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells;Antony;Journal of Immunology,2005

4. Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment;Barosi;Leukemia,2008

5. Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project;Barosi;Blood,2013

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The CALR mutations enhance the expression of the immunosuppressive proteins GARP and LAP on peripheral blood lymphocytes through increased binding of activated platelets;British Journal of Haematology;2024-08-20

2. FRACTION: protocol of a phase II study of Fedratinib and Nivolumab combination in patients with myelofibrosis and resistance or suboptimal response to JAK-inhibitor treatment of the German MPN study group (GSG-MPN);Annals of Hematology;2024-07-05

3. Aberrant RNA sensing in regulatory T cells causes systemic autoimmunity;Science Advances;2024-03

4. Ruxolitinib for the treatment of acute and chronic graft-versus-host disease in children: a systematic review and individual patient data meta-analysis;Bone Marrow Transplantation;2024-02-24

5. Targeting T regulatory (T_reg) cells in immunotherapy-resistant cancers;Cancer Drug Resistance;2024-01-12